Prevention of abdominal wound infection (PROUD trial, DRKS00000390): study protocol for a randomized controlled trial

Trials

Volumn 12, Issue , 2011, Pages

  Heger, Ulrike ^a   Voss, Sabine ^a   Knebel, Phillip ^a   Doerr Harim, Colette ^a   Neudecker, Jens ^b   Schuhmacher, Christoph ^c   Faist, Eugen ^d   Diener, Markus K ^a   Kieser, Meinhard ^a   Seiler, Christoph M ^a   Büchler, Markus W ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

POLYDIOXANONE; TRICLOSAN;

ABDOMINAL INJURY; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EXTERNAL VALIDITY; HUMAN; INTENTION TO TREAT ANALYSIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MATERIAL COATING; META ANALYSIS (TOPIC); MULTICENTER STUDY; PHASE 2 CLINICAL TRIAL; PRACTICE GUIDELINE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; STANDARDIZATION; STATISTICAL ANALYSIS; STUDY DESIGN; SUTURE; WOUND CLOSURE; WOUND INFECTION; ABDOMEN; ANTIBIOTIC PROPHYLAXIS; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; STATISTICAL MODEL; SURGICAL INFECTION;

ABDOMEN; ANTIBIOTIC PROPHYLAXIS; CLINICAL PROTOCOLS; DOUBLE-BLIND METHOD; HUMANS; LOGISTIC MODELS; QUALITY OF LIFE; SURGICAL WOUND INFECTION; SUTURES;

EID: 81355149198     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-12-245     Document Type: Article

References (29)

1. Bennett-Guerrero E, Pappas TN, Koltun WA, Fleshman JW, Lin M, Garg J, Mark DB, Marcet JE, Remzi FH, George VV, et al. Gentamicin-collagen sponge for infection prophylaxis in colorectal surgery. N Engl J Med 2010, 363:1038-1049. 10.1056/NEJMoa1000837, 20825316.
2. Hospital In Europe Link for Infection Control through Surveillance SSI Statistical Report. 2004, Hospital In Europe Link for Infection Control through Surveillance., http://helics.univ-lyon1.fr/documents/HELICS-SSI%20Stat%20Report%202004%20Final%20Version%20180406.pdf
3. Seiler CM, Bruckner T, Diener MK, Papyan A, Golcher H, Seidlmayer C, Franck A, Kieser M, Buchler MW, Knaebel HP. Interrupted or continuous slowly absorbable sutures for closure of primary elective midline abdominal incisions: a multicenter randomized trial (INSECT: ISRCTN24023541). Ann Surg 2009, 249:576-582. 10.1097/SLA.0b013e31819ec6c8, 19300233.
4. Zhan C, Miller MR. Excess length of stay, charges, and mortality attributable to medical injuries during hospitalization. JAMA 2003, 290:1868-1874. 10.1001/jama.290.14.1868, 14532315.
5. Rodeheaver GT, Kurtz LD, Bellamy WT, Smith SL, Farris H, Edlich RF. Biocidal braided sutures. Arch Surg 1983, 118:322-327.
6. McMurry LM, Oethinger M, Levy SB. Triclosan targets lipid synthesis. Nature 1998, 394:531-532. 10.1038/28970, 9707111.
7. Justinger C, Schuld J, Sperling J, Kollmar O, Richter S, Schilling MK. Triclosan-coated sutures reduce wound infections after hepatobiliary surgery-a prospective non-randomized clinical pathway driven study. Langenbecks Arch Surg 2011,
8. Justinger C, Moussavian MR, Schlueter C, Kopp B, Kollmar O, Schilling MK. Antibacterial [corrected] coating of abdominal closure sutures and wound infection. Surgery 2009, 145:330-334. 10.1016/j.surg.2008.11.007, 19231586.
9. Ming X, Rothenburger S, Nichols MM. In vivo and in vitro antibacterial efficacy of PDS plus (polidioxanone with triclosan) suture. Surg Infect (Larchmt) 2008, 9:451-457.
10. Storch ML, Rothenburger SJ, Jacinto G. Experimental efficacy study of coated VICRYL plus antibacterial suture in guinea pigs challenged with Staphylococcus aureus. Surg Infect (Larchmt) 2004, 5:281-288.
11. Gomez-Alonso A, Garcia-Criado FJ, Parreno-Manchado FC, Garcia-Sanchez JE, Garcia-Sanchez E, Parreno-Manchado A, Zambrano-Cuadrado Y. Study of the efficacy of Coated VICRYL Plus Antibacterial suture (coated Polyglactin 910 suture with Triclosan) in two animal models of general surgery. J Infect 2007, 54:82-88. 10.1016/j.jinf.2006.01.008, 16487594.
12. Diener MK, Voss S, Jensen K, Buchler MW, Seiler CM. Elective midline laparotomy closure: the INLINE systematic review and meta-analysis. Ann Surg 2010, 251:843-856. 10.1097/SLA.0b013e3181d973e4, 20395846.
13. Institute for Medical Informatics SaD, Medical University of Graz, Austria Institute for Medical Informatics SaD, Medical University of Graz, Austria., http://www.randomizer.at/
14. Paul-Ehrlich Gesellschaft für Chemotherapie e.V Erarbeitung medizinischer Therapieleitlinien. Chemotherapie Journal 2010, 19. Paul-Ehrlich Gesellschaft für Chemotherapie e.V.
15. Bhutani T, Jacob SE. Triclosan: a potential allergen in suture-line allergic contact dermatitis. Dermatol Surg 2009, 35:888-889. 10.1111/j.1524-4725.2009.01151.x, 19389086.
16. Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol 1992, 13:606-608. 10.1086/646436, 1334988.
17. Higgins JP, White IR, Wood AM. Imputation methods for missing outcome data in meta-analysis of clinical trials. Clin Trials 2008, 5:225-239. 10.1177/1740774508091600, 2602608, 18559412.
18. Bauer P, Kohne K. Evaluation of experiments with adaptive interim analyses. Biometrics 1994, 50:1029-1041. 10.2307/2533441, 7786985.
19. Engemann JJ, Carmeli Y, Cosgrove SE, Fowler VG, Bronstein MZ, Trivette SL, Briggs JP, Sexton DJ, Kaye KS. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis 2003, 36:592-598. 10.1086/367653, 12594640.
20. Kirkland KB, Briggs JP, Trivette SL, Wilkinson WE, Sexton DJ. The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol 1999, 20:725-730. 10.1086/501572, 10580621.
21. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1999, 20:250-278. quiz 279-280, 10.1086/501620, 10219875.
22. Anderson DJ, Sexton DJ, Kanafani ZA, Auten G, Kaye KS. Severe surgical site infection in community hospitals: epidemiology, key procedures, and the changing prevalence of methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 2007, 28:1047-1053. 10.1086/520731, 17932825.
23. Hedrick TL, Heckman JA, Smith RL, Sawyer RG, Friel CM, Foley EF. Efficacy of protocol implementation on incidence of wound infection in colorectal operations. J Am Coll Surg 2007, 205:432-438. 10.1016/j.jamcollsurg.2007.04.042, 17765159.
24. Fleck T, Moidl R, Blacky A, Fleck M, Wolner E, Grabenwoger M, Wisser W. Triclosan-coated sutures for the reduction of sternal wound infections: economic considerations. Ann Thorac Surg 2007, 84:232-236. 10.1016/j.athoracsur.2007.03.045, 17588420.
25. Diener MK, Simon T, Buchler MW, Seiler CM. Surgical evaluation and knowledge transfer-methods of clinical research in surgery. Langenbecks Arch Surg 2011,
26. McLeod RS. Issues in surgical randomized controlled trials. World J Surg 1999, 23:1210-1214. 10.1007/s002689900649, 10552108.
27. Ergina PL, Cook JA, Blazeby JM, Boutron I, Clavien PA, Reeves BC, Seiler CM, Altman DG, Aronson JK, Barkun JS, et al. Challenges in evaluating surgical innovation. Lancet 2009, 374:1097-1104. 10.1016/S0140-6736(09)61086-2, 2855679, 19782875.
28. Rodeheaver GT, Beltran KA, Green CW, Faulkner BC, Stiles BM, Stanimir GW, Traeland H, Fried GM, Brown HC, Edlich RF. Biomechanical and clinical performance of a new synthetic monofilament absorbable suture. J Long Term Eff Med Implants 1996, 6:181-198.
29. Chu CC, Williams DF. Effects of physical configuration and chemical structure of suture materials on bacterial adhesion. A possible link to wound infection. Am J Surg 1984, 147:197-204. 10.1016/0002-9610(84)90088-6, 6364858.